Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00876408 · ClinicalTrials.gov registry record
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
A clinical trial, sponsored by SCRI Development Innovations.
- Completed
- Registry status
- 30
- Enrollment target
NCT00876408 is a clinical trial that has completed, run by SCRI Development Innovations. The registered enrollment target is 30 participants.
The verdict
NCT00876408 has completed, sponsored by SCRI Development Innovations.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00876408
The ClinicalTrials.gov registry entry for NCT00876408 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SCRI Development Innovations, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00876408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00876408 about?
NCT00876408 is a clinical study titled "Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer". This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.
What is the current status of trial NCT00876408?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT00876408?
This trial is sponsored by SCRI Development Innovations, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.